ResMed Announces Q3 Earnings Call with Leadership Transition
ResMed (RMD) held its third-quarter earnings call for fiscal year 2026, during which CEO Michael J. Farrell announced CFO Brett A. Sandercock's retirement and the appointment of Aaron Blumer as his successor. The transition is expected to maintain financial discipline and strategic growth at ResMed.
Tickers: $RMD